Antitumor Effect of Gemcitabine on Orthotopically Inoculated Human Gallbladder Cancer Cells in Nude Mice
作者： Yoshiyasu Mita , Tetsuo Ajiki , Takashi Kamigaki , Taro Okazaki , Hiroshige Hori
DOI: 10.1245/S10434-006-9191-9
关键词:
摘要: Background The prognosis of gallbladder carcinoma is poor; therefore, investigating the efficacy new chemotherapy agents essential for treatments this tumor. Recently, several studies have reported clinical trials using gemcitabine as treatment advanced cancers. However, antitumor effects on not been examined in vitro and vivo model systems.
springer.com
core.ac.uk
sci-hub.se 参考文章(27)
A. Knuth, H. Gabbert, W. Dippold, O. Klein, W. Sachsse, D. Bitter-Suermann, W. Prellwitz, K.H. Meyer zum Büschenfelde, Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. Journal of Hepatology. ,vol. 1, pp. 579- 596 ,(1985) , 10.1016/S0168-8278(85)80002-7
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
Kazuto Habara, Tetsuo Ajiki, Takashi Kamigaki, Takeshi Nakamura, Yoshikazu Kuroda, High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro. Japanese Journal of Cancer Research. ,vol. 92, pp. 1127- 1132 ,(2001) , 10.1111/J.1349-7006.2001.TB01068.X
Hideki Horiuchi, Hitoshi Kawamata, Takahiro Fujimori, Yoshikazu Kuroda, A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model. International Journal of Oncology. ,vol. 23, pp. 957- 963 ,(2003) , 10.3892/IJO.23.4.957
Keitaro Kakinoki, Yasuhiro Fujino, Yasuyuki Suzuki, Shiri Li, Takuro Yoshikawa, Yasuki Tanioka, Yonson Ku, Yoshikazu Kuroda, Protection against ischemia/reperfusion injury by the cavitary two-layer method in canine small intestinal transplantation with reduction of reactive oxygen species Surgery. ,vol. 135, pp. 642- 648 ,(2004) , 10.1016/J.SURG.2003.10.013
Nikolas Tsavaris, Christos Kosmas, Panagiotis Gouveris, Kostadinos Gennatas, Aris Polyzos, Despina Mouratidou, Heracles Tsipras, Helias Margaris, George Papastratis, Evanthia Tzima, Nikitas Papadoniou, Gavrilos Karatzas, Efstathios Papalambros, Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Investigational New Drugs. ,vol. 22, pp. 193- 198 ,(2004) , 10.1023/B:DRUG.0000011797.09549.53
H. Burris, A.M. Storniolo, Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil European Journal of Cancer. ,vol. 33, ,(1997) , 10.1016/S0959-8049(96)00324-3
John P. Neoptolemos, Deborah D. Stocken, Helmut Friess, Claudio Bassi, Janet A. Dunn, Helen Hickey, Hans Beger, Laureano Fernandez-Cruz, Christos Dervenis, François Lacaine, Massimo Falconi, Paolo Pederzoli, Akos Pap, David Spooner, David J. Kerr, Markus W. Büchler, A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer New England Journal of Medicine. ,vol. 350, pp. 1200- 1210 ,(2004) , 10.1056/NEJMOA032295
Cathy Eng, Ramesh K. Ramathan, Michael K. Wong, Scot C. Remick, Lanting Dai, Kurombi T. Wade-Oliver, Sridhar Mani, Hedy L. Kindler, A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. American Journal of Clinical Oncology. ,vol. 27, pp. 565- 569 ,(2004) , 10.1097/01.COC.0000135924.94955.16
Takuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, Kenji Yamao, Shinichi Ohkawa, Soh Saito, Hiroshi Saito, Toshio Tsuyuguchi, Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemotherapy and Pharmacology. ,vol. 57, pp. 647- 653 ,(2006) , 10.1007/S00280-005-0095-3